Literature DB >> 27470284

The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual.

Ping Wang1, Yong Li2, Huiqiong Nie3, Xiaoyan Zhang4, Qiongyan Shao4, Xiuli Hou3, Wen Xu5, Weisong Hong5, Aie Xu5.   

Abstract

BACKGROUND: Vitiligo is a common acquired depigmentation skin disease characterized by loss or dysfunction of melanocytes within the skin lesion, but its pathologenesis is far from lucid. The gene expression profiling of segmental vitiligo (SV) and generalized vitiligo (GV) need further investigation.
OBJECTIVE: To better understanding the common and distinct factors, especially in the view of gene expression profile, which were involved in the diseases development and maintenance of segmental vitiligo (SV) and generalized vitiligo (GV).
METHODS: Peripheral bloods were collected from SV, GV and healthy individual (HI), followed by leukocytes separation and total RNA extraction. The high-throughput whole genome expression microarrays were used to assay the gene expression profiles between HI, SV and GV. Bioinformatics tools were employed to annotated the biological function of differently expressed genes. Quantitative PCR assay was used to validate the gene expression of array.
RESULTS: Compared to HI, 239 over-expressed genes and 175 down-expressed genes detected in SV, 688 over-expressed genes and 560 down-expressed genes were found in GV, following the criteria of log2 (fold change)≥0.585 and P value<0.05. In these differently expressed genes, 60 over-expressed genes and 60 down-expressed genes had similar tendency in SV and GV. Compared to SV, 223 genes were up regulated and 129 genes were down regulated in GV. In the SV with HI as control, the differently expressed genes were mainly involved in the adaptive immune response, cytokine-cytokine receptor interaction, chemokine signaling, focal adhesion and sphingolipid metabolism. The differently expressed genes between GV and HI were mainly involved in the innate immune, autophagy, apoptosis, melanocyte biology, ubiquitin mediated proteolysis and tyrosine metabolism, which was different from SV. While the differently expressed genes between SV and GV were mainly involved in the metabolism pathway of purine, pyrimidine, glycolysis and sphingolipid.
CONCLUSIONS: Above results suggested that they not only shared part bio-process and signal pathway, but more important, they utilized different biological mechanism in their pathogenesis and maintenance. Our results provide a comprehensive view on the gene expression profiling change between SV and GV especially in the side of leukocytes, and may facilitate the future study on their molecular mechanism and theraputic targets.
Copyright © 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytokine; Gene expression profile; Generalized vitiligo; Melanocyte; Segmental vitiligo

Mesh:

Substances:

Year:  2016        PMID: 27470284     DOI: 10.1016/j.jdermsci.2016.07.006

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  10 in total

1.  MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo.

Authors:  Anupama Sahoo; Bongyong Lee; Katia Boniface; Julien Seneschal; Sanjaya K Sahoo; Tatsuya Seki; Chunyan Wang; Soumen Das; Xianlin Han; Michael Steppie; Sudipta Seal; Alain Taieb; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2017-05-11       Impact factor: 8.551

2.  Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  BMC Genomics       Date:  2017-01-28       Impact factor: 3.969

Review 3.  More Than Skin Deep: Autophagy Is Vital for Skin Barrier Function.

Authors:  Payel Sil; Sing-Wai Wong; Jennifer Martinez
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

4.  Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis.

Authors:  Liisi Raam; Epp Kaleviste; Marina Šunina; Helen Vaher; Mario Saare; Ele Prans; Maire Pihlap; Kristi Abram; Maire Karelson; Pärt Peterson; Ana Rebane; Kai Kisand; Külli Kingo
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

5.  RNA-seq Reveals Dysregulation of Novel Melanocyte Genes upon Oxidative Stress: Implications in Vitiligo Pathogenesis.

Authors:  Konduru Seetharama Sastry; Haroon Naeem; Younes Mokrab; Aouatef Ismail Chouchane
Journal:  Oxid Med Cell Longev       Date:  2019-12-04       Impact factor: 6.543

6.  Identification of differentially expressed genes and signaling pathways in human conjunctiva and reproductive tract infected with Chlamydia trachomatis.

Authors:  Guo-Dong Zhu; Xun-Jie Cao; Ya-Ping Li; Jia-Xin Li; Zi-Jian Leng; Li-Min Xie; Xu-Guang Guo
Journal:  Hum Genomics       Date:  2021-04-19       Impact factor: 4.639

7.  Fatty acid-binding protein 4 circulating levels in non-segmental vitiligo.

Authors:  Azza Gaber Antar Farag; Eman A E Badr; Asmaa El-Shafey Soliman El-Shafey; Mustafa Elsayed Elshaib
Journal:  An Bras Dermatol       Date:  2021-11-25       Impact factor: 1.896

Review 8.  Shining Light on Autophagy in Skin Pigmentation and Pigmentary Disorders.

Authors:  Daniela Kovacs; Giorgia Cardinali; Mauro Picardo; Emanuela Bastonini
Journal:  Cells       Date:  2022-09-26       Impact factor: 7.666

9.  HLA-G Polymorphisms Are Associated with Non-segmental Vitiligo among Brazilians.

Authors:  Luciana Veiga-Castelli; Maria Luiza de Oliveira; Alison Pereira; Guilherme Debortoli; Letícia Marcorin; Nádia Fracasso; Guilherme Silva; Andreia Souza; Juliana Massaro; Aguinaldo Luiz Simões; Audrey Sabbagh; Renata Cardili; Eduardo Donadi; Erick Castelli; Celso Mendes-Junior
Journal:  Biomolecules       Date:  2019-09-09

Review 10.  Autoimmunity in Segmental Vitiligo.

Authors:  Reinhart Speeckaert; Jo Lambert; Vedrana Bulat; Arno Belpaire; Marijn Speeckaert; Nanja van Geel
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.